Products
HERCESSI™ (trastuzumab-strf) | Accord BioPharma
Product description
HERCESSI™ is a trastuzumab-strf biosimilar, now preferred under Express Scripts and Cigna Healthcare formularies, offering patients a reliable and affordable treatment option for HER2-positive cancers.